Crown MycoResin Biotech, Inc. (CMBI) offers investors a science-driven entry point into the high-value agarwood industry, supported by a structured ecosystem, proprietary induction technologies, and scalable plantation partnerships. Our Investor Relations framework is designed to ensure transparency, profitability, and long-term value creation.
Investment Opportunity
CMBI operates within the rapidly growing global agarwood and oud market, where demand for resin chips and essential oils continues to rise across the Middle East, Asia, and luxury fragrance sectors.
We provide investors access to:
- Managed agarwood plantation projects
- Biotech-enabled resin induction systems (BarIno™)
- Revenue-sharing and profit participation models
- Buyer linkage and export-oriented market access
Investment Models
- Contract Inoculation Revenue Share
- Investors own or partner in tree assets
- CMBI provides full induction services
- Profit sharing based on harvest proceeds
- Managed Plantation Investment
- End-to-end plantation development
- Integrated with the Crown Ecosystem
- Long-term asset appreciation + harvest income
- Technology-Driven Yield Enhancement
- Upgrade existing plantations using BarIno™ systems
- Increase resin yield, quality, and market value
Return Drivers
Investor returns are driven by:
- Tree maturity & DBH class
- Resin grade and yield per tree
- Market price per kg (chips/oil)
- Efficiency of induction protocols
- Access to premium buyers
Value Chain Integration Advantage
Through the Crown Ecosystem, CMBI ensures:
✔ Controlled production from planting to processing
✔ Reduced dependency on third parties
✔ Higher value capture across stages
✔ Consistent product quality and traceability
Governance & Transparency
CMBI is committed to:
- Clear Contract Inoculation Agreements (CIA)
- Structured Schedules (A–F) for operations and financials
- Regular monitoring and reporting
- Transparent revenue and cost computation
- Ethical and compliant business practices
Investment Timeline (Indicative)
| Phase | Timeline |
|---|---|
| Plantation Establishment | Year 0–2 |
| Tree Growth | Year 2–5 |
| Resin Induction | Year 4–6 |
| Harvest & Monetization | Year 5–7 |
Market Position
CMBI is strategically aligned with:
- Growing demand in Middle East markets (Oud)
- Expansion of luxury fragrance industries
- Increasing global interest in natural and sustainable products
Investor Support Services
- Project structuring & feasibility
- Technical advisory & plantation setup
- Induction and monitoring services
- Harvest planning and valuation
- Buyer linkage and offtake coordination
Investor Value Proposition
“Agarwood is not just a crop—it is a high-value biological asset. With CMBI’s science-driven systems, investors gain access to a structured, scalable, and globally competitive opportunity.”
📞 Contact Information
Crown MycoResin Biotech, Inc.
📧 Email: inquiry@barino.tech/
🌐 Website: https://barino.tech/
📱 Contact: +63 46 418 9530